XML 144 R125.htm IDEA: XBRL DOCUMENT v3.6.0.2
Company Financial Information - Additional Information (Details) - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Jan. 01, 2017
Aug. 01, 2016
Jun. 29, 2016
Mar. 11, 2015
Condensed Financial Statements, Captions [Line Items]              
Liquid asset held, amount $ 1,300,000,000            
Dividend payout ratio that when exceeded begins to receive close scrutiny from fed 30.00%            
Stock repurchase progam, authorized amount, prior to satisfying contingency of prior preferred stock issuance           $ 2,140,000,000  
Stock repurchase program, additional authorized amount after preferred stock issuance prerequisite           560,000,000  
Authorized amount of shares to repurchase           $ 2,700,000,000.0 $ 3,102,000,000.000
Preferred stock, amount         $ 1,000,000,000    
Average reserve balances with federal reserve banks $ 6,000,000,000 $ 6,500,000,000          
Bank Subsidiaries              
Condensed Financial Statements, Captions [Line Items]              
Common stock, dividends declared $ 160,000,000 $ 182,000,000 $ 809,000,000        
Credit Extensions To Affiliates              
Condensed Financial Statements, Captions [Line Items]              
Maximum percentage of regulatory capital allowable for bank credit extensions 10.00%            
Credit Extensions In Aggregate To Bank Of New York And All Affiliates              
Condensed Financial Statements, Captions [Line Items]              
Maximum percentage of regulatory capital allowable for bank credit extensions 20.00%            
Minimum              
Condensed Financial Statements, Captions [Line Items]              
Collateral percentage requirement for bank loans to affiliates 100.00%            
Maximum              
Condensed Financial Statements, Captions [Line Items]              
Collateral percentage requirement for bank loans to affiliates 130.00%            
Subsequent Event              
Condensed Financial Statements, Captions [Line Items]              
Dividend payments without regulatory approval       $ 5,400,000,000